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Objectives.The primary purpose of this study was to evaluatemyoelectrically controlled functional electrical stimulation (MeCFES)
for enhancing the tenodesis grip in people with tetraplegia. The second aim was to estimate the potential number of candidates for
theMeCFES device.The application ofMeCFES provides the user with direct control of the grasp force as opposed to triggered FES
systems.Methods. Screening 253 medical records of C5 to C7 spinal cord injury resulted in 27 participants who trained activities of
daily living for 12 × 2 hours, using the MeCFES. Hand function was evaluated by the Action Research Arm Test (ARAT). Primary
outcome was the ARAT change score with/without the device, before/after the intervention period. Secondary outcome was the
number of positive or clinically relevant change scores with respect to the cohort. Results.TheMeCFES improved hand test score in
63% of the subjects at first application. Training resulted in a significant therapeutic effect, which resulted in an overall increase of
hand function in 89% of the participants and 30% experienced a clinically relevant change (6 points or more). Conclusions. Clinical
relevance was found both as an assistive aid and as a therapeutic tool in rehabilitation. The therapeutic effect deserves further
investigation in clinical studies.
1. Introduction
The majority of cervical spinal cord injuries fall into the seg-
ment of C5–C7 [1]. Such lesions will spare proximal control
though severely impairing the hand function. Improvement
of the hand function is highly prioritized among tetraplegic
individuals [2] due to its impact on personal independence
[3]. Early after the lesion, conservative management of the
hand aims to promote the tenodesis grip [4]. If the passive
mechanical tenodesis properties are adequate, this grip is
used as follows: with the wrist in flexion, the fingers are
manipulated around the target. Then the wrist is actively
extended, causing passive finger flexion and the target can
then be held. The effectiveness of the tenodesis for activities
of daily living (ADL) depends in part on the resulting grasp
force [4]. Reconstructive surgery [5] or implanted functional
electrical stimulation (FES) devices [6] may improve grasp
[7]. Yet, some patients may refrain from surgery [2]. Surface
stimulation systems often precede implanted systems, since
they can be applied without commitment and safety issues
and have demonstrated their validity as an assistive technol-
ogy for daily use [2, 8, 9].
FES systems are typically controlled by shoulder move-
ments [6] or triggered to activate a fixed stimulation sequence
[8, 9].Though direct myoelectric control has the advantage of
being cognitively simpler to use, it has received less attention
[10–12]. As for the expected number of users, it has been
estimated that 60%of the tetraplegic population could benefit
from reconstructive surgery [5] and 7% could be candidates
for an implanted FES system [13]. It is generally estimated that
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nearly half the population with a C5 to C7 neurological level
would be interested in such assistive technologies [2, 8, 9, 13].
The effect of training ADL in occupational therapy is
assumed to be beneficial and is a key element in the rehabilita-
tion process [14].Thoughmany aspects besides functionmust
be taken into account when evaluating assistive technologies
[15], performance testing of hand function is central.
Upper limb evaluation tools, specific for tetraplegia, are
used in the scientific literature (e.g., the Sollerman hand
function test [16] and the grasp-and-release test [17]) and
still more are being proposed (e.g., the AuSpinal [18], the
Van Lieshout test [19], and the GRASSP [20]). Recently,
also the more general Action Research Arm Test (ARAT)
[21] has been used in studies targeting the tetraplegic hand
[22].
A previous study on myoelectrically controlled FES
(MeCFES) demonstrated that active wrist extension could be
used to control the stimulation of the finger flexors, so as to
enhance the tenodesis grip. Specifically, the active muscles
were in direct control of the stimulation intensity and, as a
consequence, an increase of wrist extension was producing
increasingly more finger flexion. In a 20-subject convenience
sample, 5 hands gained an immediate improvement of the
system with respect to nonuse of the system [12].
The purpose of this research paper is to quantify how
much hand function can be improved with the MeCFES
device both immediately and in the longer terms and to
estimate the proportion of subjects with tetraplegia who
would benefit from this method.
2. Methods
We conducted this study at the two largest spinal units in
northern Italy. The study had the following five stages: (1)
screening a cohort of clinical records to register cases of
cervical spinal cord lesion and identify candidates for the
neuroprosthesis; (2) asking candidates to participate in a (3)
clinical evaluation of the hand function; (4) inviting subjects
fulfilling inclusion criteria to participate in an intervention
period of occupational therapy; (5) a final evaluation of the
hand function (see flowchart of the study Figure 1). The
purposewas to estimate howmany subjects would participate
in the study andwhat fraction of them resulted candidates for
the neuroprosthesis and how much they would gain in hand
function.
2.1. The Neuroprosthesis. The neuroprosthesis was a one-
channel battery powered portable research prototype imple-
menting myoelectrically controlled functional electrical
stimulation (MeCFES) [12]. The myoelectric signal was
processed such that the stimulation amplitude would be a
smoothened estimate of the muscle activity. Stimulation was
a biphasic 300 𝜇s current pulse with 16 pulses per second.
The stimulation amplitude was calculated as a gain times
the offset compensated estimate of volitional myoelectric
activity. An upper limit was applied to avoid excessive stim-
ulation [23, 24]. Standard surface self-adhesive stimulation
electrodes (Axelgaard, Fallbrook, USA) and EMG recording
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Figure 1: Flowchart of the study. The outcome measures were the
ARAT test scores obtained in two times and two conditions: natural
(AN) and with the MeCFES (AM), before (subscript zero) and after
(subscript one) the training period.
electrodes (Kendall Arbo; Covidien, Germany) were used
and connected to the MeCFES unit by flexible cables. During
exercises this was put in a pocket of the patient ormounted on
the wheelchair. Electrode positions were identified for each
patient by trial-starting with recording electrodes over the
muscle belly of extensor carpi radialis/ulnaris and stimulation
electrodes over the flexor digitorum superficialis and/or
flexor polices longus and then modified to optimise control
and provide functional finger and/or thumb flexion. The
system was calibrated for each patient by a laptop connected
to the device. Parameters were iteratively adjusted by the
clinician to obtain direct control of finger flexion as being
directly related to the amount of wrist extension. Thus,
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the user would have direct control of the stimulation intensity
by the degree of volitional wrist extension in synergy, adding
force to the tenodesis grasp [12].
2.2. Outcome Measurement. The ARAT presents the best
trade-off between time to administer and validity/reliability
regarding the intervention [22]. To minimize muscle fatigue
and burden on the patient, it was chosen to include no other
performance evaluations [25]. This test has been validated
[26] against the Fugl-Meyer assessment [27], the Sollerman
test (𝑟 = 0.94) [28], and other common hand function
tests [27, 29]. It is categorized with grasp, grip, pinch, and
gross movement; lifting and moving blocks of various sizes,
pouring water, picking up, and placing small objects; and
gross movement of hand to mouth, head, and neck. It
measures the performance of specific tasks on a scale from 0
to 57 under standardised conditions. A positive change score
exceeding 5.7 is considered clinically relevant [26].
2.3. Recruitment of Participants. First, the databases of the
spinal units were screened to select records of cervical spinal
cord lesions. Records of (re)admission within an eight-year
period were collected. In the second stage, subjects with
C5 to C7 neurological level of lesion, time since onset in
excess of 6 months, and age between 18 and 80 years were
contacted. Exclusion criteria were presence of implanted
devices, cardiovascular problems, epilepsy, peripheral lesion
of the brachial plexus, and respiratory, renal, cardiac, and
cognitive and aphasic problems. Contacted subjects were
furthermore inquired for their hand status and excluded if no
hand was functional or if both hands were fully functional. In
stage 3, subjects willing and able to participate were seen in
the clinic to verify if they had wrist extension above grade
1 on the MRC scale and innervation of the finger flexors,
that is, motor response to stimulation of the finger and/or
thumb flexors. Subjects were excluded if none of the hands
were functional. Nonfunctional hands were characterized by
adverse spasticity, contractures, deformities, or important
range of movement limitations of the joints. Subjects with
both hands fully functional (i.e., completing all tasks in the
ARAT) were also excluded. Motor response was tested with a
stimulation intensity of maximal tolerable level up to 60mA.
If the resulting movement was not functional (as described
above), the subject was excluded upon their own request.
For patients, not excluded at this point, the MeCFES
parameters and setup were established. Then the ARAT was
administered to establish the baseline score with the device
off (natural score—AN
0
) and with the device active (score
with the MeCFES—AM
0
). Finally, if the subject were still
eligible and willing to participate, an intervention period was
scheduled. In this fourth stage, individually prioritised tasks
that involved the use of the tenodesis grip (primarily palmar
prehension andpinch grip)were trained using the neuropros-
thesis. At least 12 two-hour sessions, under supervision of
an occupational therapist, were to be completed within two
months. After the intervention period, the final evaluation
with the ARATwas made with (AM
1




Workshops were held before starting the study to train
involved clinical staff in the ARAT administration, safety
procedures, and set-up and working of the MeCFES. The
study was approved by local medical ethics committees and
the Ministry of Health.
2.4. Data Processing. We defined the following terms and


















. The immediate effect is the difference
in ARAT score that the MeCFES induces at first application.
The therapeutic effect is the change of ARAT from start to end
of intervention, as obtained without stimulation. This would
reveal a carry-over effect of the intervention. The training
effect is the change in ARAT with the neuroprosthesis
activated, from start to end of intervention period.Thiswould
indicate howmuch better or worse the subject would perform
with the system, due to training. Finally, the combined
effect is the comparison with the baseline before applying
the neuroprosthesis to the end of training period with the
neuroprosthesis and would indicate the combined result of
training and assistive effect of stimulation that the system
could induce. Primary outcomes were the median ARAT
change scores and secondary outcomes were the proportions
of subjects having positive change scores and the proportions
exceeding the clinical relevant improvement.
Descriptive statistics were calculated as median and
interquartile range (IQR [25%, 75%]) for the primary out-
comes, age, time since onset of spinal lesion and the neuro-
logical level.The 95% confidence intervals (95%CI) were cal-
culated for proportions the number of positive change scores
and change scores that exceeded the clinically relevant level.
Comparisons were made in MedCalc using nonparametric
statistics (Wilcoxon signed-rank test). Levels were ranked
(C5, C6, and C7) for the statistical analysis. Age, time since
onset and neurologic level were correlated with the primary
outcomes using the Spearman rank correlation (𝜌). In a post
hoc analysis, the Kruskal-Wallis (or Mann-Whitney 𝑈 test),
was used to test differences in the various stages with respect
to age, time since onset, level, sex and spinal unit.
3. Results
3.1. Participants. Screening the spinal unit databases for
patients admitted for the last 8 years resulted in 𝑁
0
= 253
records of cervical spinal cord level with complete anamnesis
and contact information. Both units had similar (𝑃 = 0.2)
number of cases, 131 versus 122. The median age was 40 (IQR
[31; 54]), time since onset was 8 years (IQR [5; 14]), and 213
(84%) of the screening population weremales. After applying
the level, age, and health status exclusion criteria, 𝑁
1
=
169 records with C5–C7 level of lesion were considered for
physical examination in stage 2 (see Figure 1). These subjects
were contacted and asked to participate in the study and
𝑁
2
= 79 subjects (95% CI [25%; 37%]) were willing and able
to undergo the clinical examination in stage 3.
The clinical examination excluded further 50 subjects due
to lack of motor response to the stimulation, nonfunctional
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Table 1: Reasons for exclusion in the three first stages of selection.
Exclusion in stage 1 Exclusion in stage 2 Exclusion by examination
By level 70 By health problems 5 No innervation 24
By age 3 No functional hand 10 No functional hand 11
Death/disease 11 Near normal hands 10 No gain by stimulation 9




) 84 Total (𝑍
2
) 90 Total (𝑍
3
) 50
hands, and active hands that could not be increased by
MeCFES or refusal to continue (see Table 1 for details). The
dominant hand was used in all cases (20 right-handers).
3.2. Intervention. Thus 29 subjects were enrolled forMeCFES
assisted occupational therapy programme, training the prior-
itized ADL for two hours under guidance of the occupational
therapists. A plurality of activities were prioritized. These in
order of occurrence were writing, dressing, dining, cooking,
manipulating small or heavy objects, putting books on
shelves, and so forth. Also special activities like personal
hygiene and, for example, loading the wheelchair into their
car, were trained. All subjects except two drop-outs (a surgical
intervention and a botulinum toxin treatment) completed
the intervention period, training ADL with the MeCFES.
Thus final measurements were taken on 𝑁
4
= 27 compliant
patients equalling to 11% (95% CI [7%, 15%]) of the cohort.
The ARAT scores from the four conditions are listed in
Table 2.
3.3. Primary Outcomes. Figure 2 shows the histogram plots
for the distribution of the change scores of the immediate,
therapeutic, training, and the combined effects.





increasing the hand function in 63% of the compliant sub-
jects, of whom 15% exceeded the clinically relevant change
of at least 5.7 ARAT points. Though less pronounced, we





means that 56% of the subjects improved the hand function
as a carry-over effect from the MeCFES intervention period.
However, this effect was small and none of the subjects
exceeded the clinical relevant threshold.




), we found a highly
significant increase of 2 points. Thus training had increased
the ARAT score in 67% of the participants and in 11%, this
change was clinically important.





highly significant median increase of 4 (IQR [2.3, 4.8]) points
of the test score yielding 89% of enrolled patients or 9% (95%
CI [6%, 14%]) of the screening sample (𝑁
0
). Of these, eight
(30%) exceeded the clinically relevant change. See Table 3.
Some subjects decided to complete the protocol though
not having an immediate improvement of the ARAT score,
because they experienced improved grasp on specific tasks.
These subjects actually improved during the intervention
period and the change was attributable to items of the ARAT
requiring strength (grasp and pouring).
Table 2: ARAT scores sorted by spinal unit (UN/US) then neuro-
logical level ASIA scale and AIS (ASIA impairment scale). Scores
with the MeCFES off (AN0/1) and with the MeCFES active (AM0/1)
before (0) and after (1) the intervention period.Data are summarized
as median values with interquartile ranges (IQR). Clinically relevant
changes exceeding 5.7 points are marked§.
Patient Level AIS AN0 AM0 AN1 AM1
UN(1) C5 A 15 11 14 15
UN(2) C5 A 16 15 19 18
UN(3) C5 A 26 19 23 27
UN(4) C5 A 31 31 32 33
UN(5) C5 A 32 29 37 33
UN(6) C5 A 33 33 35 33§
UN(7) C5 A 31 35 36 37
UN(8) C5 B 18 18 20 23§
UN(9) C6 A 14 13 19 20
UN(10) C6 A 24 21 21 23
UN(11) C6 A 27 28 29 30
UN(12) C6 B 18 16 20 20
UN(13) C6 B 25 32§ 25 34§
UN(14) C6 B 26 31 27 29
UN(15) C6 C 40 41 40 44
UN(16) C7 B 28 30 33 35§
UN(17) C7 B 34 36 38 37
US(18) C6 A 25 28 26 28
US(19) C6 A 28 31 28 36§
US(20) C6 A 19 27§ 20 28§
US(21) C6 A 32 37 32 38§
US(22) C6 A 36 40 36 39
US(23) C6 A 38 44§ 38 43
US(24) C6 A 40 43 40 43
US(25) C7 A 45 48 47 46
US(26) C7 A 25 29 25 29
US(27) C7 A 41 49§ 41 49§
Median 28 31 29 33
IQR [25; 34] [24; 37] [22; 37] [28; 38]
3.4. PostHoc Analysis. We investigated possible relations
between baseline natural ARAT (AN
0
) score and change
scores. Correlations with immediate, therapeutic, or com-
bined effects were poor and nonsignificant. A negative
correlation (𝜌 = −0.5, 𝑃 = 0.006) of the training effect
with baseline score was found. Ranked level of lesion and
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Figure 2: Histogram plots for the change scores with lines at zero, median, and 5.7 points limits.
Table 3: Summary of change scores of the 27 patients completing the intervention period: immediate (AM0-AN0), therapeutic (AN1-AN0),
training (AM1-AM0), and combined effect (AM1-AN0) with interquartile range. Number of positive change scores and number of clinically
relevant improvements are listed in the last two rows together with their 95% confidence intervals.
Change score AM0-AN0 AN1-AN0 AM1-AM0 AM1-AN0
Median [IQR] 2 [−1, 4] 1 [0, 2] 2 [0, 4] 4 [2, 6]
(Wilcoxon—𝑃) (𝑃 < 0.02) (𝑃 < 0.01) (𝑃 < 0.0001) (𝑃 < 0.0001)
Count of positive change scores 17 15 18 24
95% CI [44%, 78%] [37%, 72%] [48%, 81%] [72%, 96%]
Count exceeding 5.7 points 4 0 2 8





) were positively correlated (𝜌 =
0.5, 𝑃 = 0.005). However, the other change scores were non-
significantly correlated with level.
No significant associations between sex or time since
onsetand selection process or primary outcomes (immediate-
, therapeutic-, training- and combined effect of MeCFES)
were found. However, there was an association between
spinal unit and the immediate effect (𝑃 = 0.003). Subjects
with initially negative immediate effect were all from the
same spinal unit and this unit had larger training effects
(𝑃 < 0.03). Small non-significant correlations were found
with respect to age and time since lesion in all change scores.
The selection process (stage 1 to 3) had a significant trend
(𝑃 < 0.01) towards examining subjects of a lower age from
the cohort, but subjects completing the protocol (stage 5)
were not significantly different (𝑃 = 0.47) from the examined
group (stage 3). No accidents or adverse effects related to the
MeCFES use were experienced.
4. Discussion
Clinical relevance of an assistive technology is influenced by
the function it offers and the amount of potential candidates
as well as the possibility to access these candidates in a
cost effective way. By screening electronic databases about
a third could be excluded. Another third were excluded
mostly due to logistic problems when making contact. It can
be questioned if some of these would be candidates for a
neuroprosthesis, thus presenting a conservative bias of the
final estimate.Themore resource consuming process was the
clinical evaluation involving the last third of the cohort.
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4.1. Limitations. Electrode location was time consuming and
subject to individual variations. In general, it was possible
to adjust the coordination of thumb and finger flexors by
modifying the placement of one or both electrodes and hence
to some extent control the individual activation of thumb and
fingers, permitting a functional grasp. The possibility to thus
control multiple muscle activations by a single channel has
practical advantages when placing electrodes. However, from
a technical standpoint it has been clinically observed that it
would be better to employmore channels for selective muscle
stimulation.
In this study, only one of the hands was included. It was
however observed and tested during the study that at least two
of the compliant subjects could benefit frombilateral systems.
Bilateral application merits further investigation.
There was a significant difference at baseline between
the spinal units with respect to recruiting subjects for the
intervention period. This may imply that one unit was more
conservative when enrolling patients who did not show
immediate benefit of the neuroprosthesis, hence potentially
not including subjects that could benefit from training.
Being a prototype, mounting electrodes and adjusting
system parameters had to be taken care of by well-trained
clinicians. However, one subject was able to don the system
by himself after some training. Some technical problems
were encountered with establishing correct electrode contact
and positioning. This as well as the difficulty of the iterative
MeCFES parameter adjustment was resulting in suboptimal
application in some cases. Wires connecting electrodes with
the electronic device were prone to breakages and tangles.
This also caused some inconveniences.
We found no significant differences of sex, age, time since
onset and, level with respect to other studies [1, 13, 30, 31] and
we therefore believe that our sample is representative for the
spinal cord population. Our estimate of potential candidates
is also in line with the findings of Gorman et al. [13] and may
thus be realistic, if not conservative.
4.2. Implications. A safe method of improving hand function
has been demonstrated. Eventually a less cumbersome imple-
mentation of the myoelectric controlled FES is imperative for
allowing full benefits for the patient.
To test compliance with activities of daily living, the
neuroprosthesis was tested by the subjects for a period in
an occupational therapy setting. During this period, patients
and therapists found that the neuroprosthesis allowed the
execution of new tasks that required more grasp force.
Surprisingly a therapeutic effect was discovered showing
that the intervention may provide functional recovery. It
should be addressed specifically in further studies, whether it
is because the neuroprosthesis permitted exploring new grasp
strategies, due to neuromuscular changes [32] induced by the
stimulation [33] or simply a training effect of occupational
therapy. This should be confirmed in a controlled study.
Most likely candidates have C6/7 level of lesion, but also
people with C5 may benefit even though the immediate
effect was lesser than for C6/7 level subjects. An immediate
improvement of hand function seems a good starting point
for deciding whether to employ the method and taking into
account that training may increase the effect. The negative
correlation between initial ARAT score and the effect of train-
ingmay imply that less functional hands aremore susceptible
to training. An explanation could be that the encouraged use
of the hands strengthens atrophied muscles in the otherwise
nonused hand. Further studies should investigate dose-
response effect to establish optimal application duration.
Another issue to address is if the training has to be supervised
by an occupational therapist or if it could be considered as a
habituation period during home use. In general, the patients
reported that the MeCFES was useful for practical activities,
even in cases where it was not evident from the ARAT change
score. We will analyse this finding further.
In conclusion, we found that a noninvasive neuroprosthe-
sis has demonstrated that it can enhance the tenodesis grip
of subjects with a cervical spinal cord lesion. The device uses
myoelectric signals from wrist extension to control neuro-
muscular stimulation of the finger flexors. Approximately 9%
of the cervical spinal cord population may be candidates for
the technique. The majority of ineligible subjects (2/3 of the
cohort) were excluded by screening of clinical records and
telephonic contact. The remaining ineligible patients were
excluded after a clinical examination.
Long-term testing in an occupational therapy setting
demonstrated that the method is useful for activities of daily
living and a clinically relevant improvement of the hand
function is documented through hand function testing.
Besides the immediate effect, there might be some
therapeutic benefits to investigate employing this kind of
neuroprosthesis in the occupational therapy.
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